Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Other Accumulated Expenses (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Other Accumulated Expenses came in at $42.1 million in Q2 2026, down 6.19% on a YoY basis from $44.9 million in Q2 2025, and down 12.61% quarter-over-quarter from $48.2 million in Q1 2026.

Analysis

Medpace Holdings (MEDP) Other Accumulated Expenses (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has reported Other Accumulated Expenses for 12 consecutive years, with $42.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Accumulated Expenses fell 6.19% year-over-year to $42.1 million; the trailing twelve-month figure through Jun 2026 stood at $42.1 million (down 6.19% YoY), and the FY2025 full-year result was $52.8 million, down 1.49% from the prior year.
  • Other Accumulated Expenses declined to $42.1 million in Q2 2026 per MEDP's latest filing, from $48.2 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $62.5 million in Q1 2023 and bottomed at $25.9 million in Q2 2022.
  • Historically, Other Accumulated Expenses has averaged $43.6 million across 5 years, with a median of $43.4 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses soared 96.94% in 2023, then slipped 28.65% in 2024.
  • Over 5 years, Other Accumulated Expenses stood at $47.5 million in 2022, then declined by 14.95% to $40.4 million in 2023, then jumped by 32.62% to $53.6 million in 2024, then slipped by 1.49% to $52.8 million in 2025, then retreated by 20.31% to $42.1 million in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $42.1 million, $48.2 million, and $52.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.10 Mn
Mar 31, 2026 48.18 Mn
Dec 31, 2025 52.83 Mn
Sep 30, 2025 54.32 Mn
Jun 30, 2025 44.88 Mn
Mar 31, 2025 56.18 Mn
Dec 31, 2024 53.63 Mn
Sep 30, 2024 37.35 Mn
Jun 30, 2024 34.62 Mn
Mar 31, 2024 44.62 Mn
Dec 31, 2023 40.44 Mn
Sep 30, 2023 35.96 Mn
Jun 30, 2023 41.35 Mn
Mar 31, 2023 62.54 Mn
Dec 31, 2022 47.55 Mn
Sep 30, 2022 30.88 Mn
Jun 30, 2022 25.90 Mn
Mar 31, 2022 31.76 Mn
Dec 31, 2021 27.61 Mn
Sep 30, 2021 30.07 Mn